Consistent with the stated objectives of this RFA, the goal of this technology core is to furnish a suite of biochemical tools, reagents and assays that will serve as the basis for generating experimental evidence for the """"""""biochemical function(s) of hypothetical genes and unknown ORFs, and function(s) of noncoding RNAs"""""""" by """"""""generating targeted measurements."""""""" While equally important, methods for profiling of proteins and small molecules are far more limited in breadth and scope than those for genes and nucleic acids. The reasons for this disparity are multiple, but, to a large degree, reflect key technological limitations associated with the increased complexity of protein structure function relationships and the atomic, rather than molecular, diversity of biochemical reactions. Notwithstanding, this core leverages key technological expertise in (i) high throughput protein biochemistry, often found only in industrial settings or laboratories focused primarily, if not exclusively, on structure, rather than activity, to enable the rapid and efficient production and characterization of proteins of unknown function;and (ii) high resolution mass spectrometry-based metabolomics to enable massively parallel and conceptually unbiased biochemical screens and/or assays for protein activity in vitro and within the native biochemical milieu of the cell. With published, and largely pioneering, expertise in each of these areas specifically applied to Mycobacterium tuberculosis (Mtb), we now propose to organize these activities into a formal technology core that will serve and inform the biochemical activities of each research project. * Activity 1: Clone, express and purify recombinant Mtb proteins of unknown function for in vitro biochemical characterization and assays. * Activity 2: Conduct in vitro assays to identify substrates and products of these putative enzymes. * Activity 3: Develop in vitro biochemical assays for putative enzymes. * Activity 4: Perform unbiased metabolomic screening for protein function

Public Health Relevance

TB is the leading bacterial cause of deaths worldwide and a pathogen of pandemic proportion. However, like the case for most microbes, its most unique attributes, and potentially most selective targets, are encoded by genes of unknown function. The establishment of the metabolomic and biochemistry core proposed herein will help fill this gap in knowledge.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard University
United States
Zip Code
Sakatos, Alexandra; Babunovic, Gregory H; Chase, Michael R et al. (2018) Posttranslational modification of a histone-like protein regulates phenotypic resistance to isoniazid in mycobacteria. Sci Adv 4:eaao1478
Lehmann, Johannes; Cheng, Tan-Yun; Aggarwal, Anup et al. (2018) An Antibacterial ?-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis. Angew Chem Int Ed Engl 57:348-353
Gerrick, Elias R; Barbier, Thibault; Chase, Michael R et al. (2018) Small RNA profiling in Mycobacterium tuberculosis identifies MrsI as necessary for an anticipatory iron sparing response. Proc Natl Acad Sci U S A 115:6464-6469
Xu, Weizhen; DeJesus, Michael A; Rücker, Nadine et al. (2017) Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 61:
Guinn, Kristine M; Rubin, Eric J (2017) Tuberculosis: Just the FAQs. MBio 8:
Rego, E Hesper; Audette, Rebecca E; Rubin, Eric J (2017) Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity. Nature 546:153-157
Jansen, Robert S; Rhee, Kyu Y (2017) Emerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome. Trends Pharmacol Sci 38:393-405
Köster, Stefan; Upadhyay, Sandeep; Chandra, Pallavi et al. (2017) Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA. Proc Natl Acad Sci U S A 114:E8711-E8720
Rock, Jeremy M; Hopkins, Forrest F; Chavez, Alejandro et al. (2017) Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat Microbiol 2:16274
Mishra, Bibhuti B; Lovewell, Rustin R; Olive, Andrew J et al. (2017) Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat Microbiol 2:17072

Showing the most recent 10 out of 33 publications